CHR is open, and medical travel to NYC is possible.Learn more.


Medically reviewed by Norbert Gleicher, MD, FACOG, FACS - Written by CHR Staff - Updated on Nov 15, 2014


Speaker: Dr. Norbert Gleicher


Video Transcript

"只要用可靠的科技,性选择就是可靠的。在网络上、在几个诊所,有很多还没证实的性选择方式。最可靠的性选择方式就是IVF。iIVF产生胚胎,用"PreimplantationGenetic Diagnosis"(PGD) 或者 胚胎植入前遗传学筛查 "Preimplantation Genetic Screening"(PGS)检测胚胎 为了知道是男或女的,然后只抱客户偏向的胚胎 放在子宫里。有特别好的方法学,几乎百分之百精确的。在CHR我们用IVF和我以前提到的PGD或者PGS。"

  • 因为CHR用IVF和PGD,所以性选择是很可靠的。
  • 用IVF和PGD的性选择是最可靠的,几乎百分之百精确的。

TEXT: Gleicher医生在纽约是CHR的创始人和主任。他有三十年以上的在生殖确置W工作的经验。他在很有名的报刊出版了几个科学的散文,也写和编辑了几个很出名的课本。他给几个编辑委员会当作某物用了,而且在会议时常地讲座。

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.